Brahmer, J. R., Dahlberg, S. E., Gray, R. J., Schiller, J. H., Perry, M. C., Sandler, A., & Johnson, D. H. (2011). Sex Differences in Outcome with Bevacizumab Therapy: Analysis of Patients with Advanced-Stage Non-Small-Cell Lung Cancer Treated with or without Bevacizumab in Combination with Paclitaxel and Carboplatin in the Eastern Cooperative Oncology Group Trial 4599.
Dyfyniad Arddull ChicagoBrahmer, Julie R., Suzanne E. Dahlberg, Robert J. Gray, Joan H. Schiller, Michael C. Perry, Alan Sandler, and David H. Johnson. Sex Differences in Outcome With Bevacizumab Therapy: Analysis of Patients With Advanced-Stage Non-Small-Cell Lung Cancer Treated With or Without Bevacizumab in Combination With Paclitaxel and Carboplatin in the Eastern Cooperative Oncology Group Trial 4599. 2011.
Dyfyniad MLABrahmer, Julie R., et al. Sex Differences in Outcome With Bevacizumab Therapy: Analysis of Patients With Advanced-Stage Non-Small-Cell Lung Cancer Treated With or Without Bevacizumab in Combination With Paclitaxel and Carboplatin in the Eastern Cooperative Oncology Group Trial 4599. 2011.